What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.23%
Annual Rate
CNY 0.15Paid annual
Payout Ratio
44.3%Sustainable
Last Ex-Dividend
Jun 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.66BCNY
1.29B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
81.52x
Updated Sep 22, 2026
Revenue (TTM)
2.07BCNY
309.53M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
5.13%
Updated Sep 22, 2026
Beta
0.6170x
vs all stocks
Updated Sep 22, 2026
52-Week Change
19.00%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
8.66BCNY
1.29B · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
9.34BCNY
1.39B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
81.52x
Updated Sep 22, 2026
Forward P/E
20.72x
Updated Sep 22, 2026
Price to Sales (TTM)
4.20x
Updated Sep 22, 2026
Price to Book (MRQ)
4.37x
Updated Sep 22, 2026
Enterprise to Revenue
4.50x
Updated Sep 22, 2026
Enterprise to EBITDA
44.02x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 33.81×.Updated Sep 22, 2026
Gross Margin
29.67%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 26.33%.Updated Sep 22, 2026
Profit Margin
5.13%
Updated Sep 22, 2026
Operating Margin
12.54%
Updated Sep 22, 2026
Return on Assets (TTM)
2.27%
Updated Sep 22, 2026
Return on Equity (TTM)
5.99%
Updated Sep 22, 2026
Revenue (TTM)
2.07BCNY
309.53M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
15.40CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
0.50%
Updated Sep 22, 2026
Gross Profit (TTM)
545.91MCNY
81.49M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
276.13MCNY
41.22M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
106.46MCNY
15.89M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-7.80%
Updated Sep 22, 2026
Operating Cash Flow (TTM)
269.85MCNY
40.28M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
103.99MCNY
15.52M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.1500CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
0.23%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
44.30%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 18.99%.Updated Sep 22, 2026
Minority Interest (Equity)
149.52MCNYFY2025 · Dec 31, 2025
Revenue
1.93BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.43BCNYFY2025 · Dec 31, 2025
Gross Profit
499.95MCNYFY2025 · Dec 31, 2025
Operating Income
161.47MCNY
24.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
152.82MCNYFY2025 · Dec 31, 2025
Income Tax Expense
15.77MCNYFY2025 · Dec 31, 2025
Net Income
137.06MCNYFY2025 · Dec 31, 2025
EBIT
179.61MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
276.13MCNYFY2025 · Dec 31, 2025
Research & Development
102.70MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
87.66MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.22MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
6.85MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
26.79MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.9000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.9000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
134.55MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
134.55MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
137.06MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-15.96MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
305.27MCNYFY2025 · Dec 31, 2025
Free Cash Flow
59.27MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
842.92MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
137.06MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
33.95MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
38.58MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
95.68MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-246.00MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-87.32MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.03BCNYFY2025 · Dec 31, 2025
Sale of Investments
990.37MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-370.43MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
671.08MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-676.84MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-52.32MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-10.45MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-68.53MCNYFY2025 · Dec 31, 2025
Shares Outstanding
135.25MSharesUpdated Sep 22, 2026
Float Shares
53.01MSharesUpdated Sep 22, 2026
% Held by Insiders
59.76%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
9.71%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
799.48MCNY
119.34M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
5.91CNYUpdated Sep 22, 2026
Total Debt (MRQ)
974.14MCNY
145.41M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.4539x
Updated Sep 22, 2026
Current Ratio (MRQ)
1.66x
Updated Sep 22, 2026
Book Value per Share (MRQ)
14.73CNYUpdated Sep 22, 2026
Total Assets
4.10BCNY
612.04M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.93BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.03BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.17BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
402.14MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.62BCNYFY2025 · Dec 31, 2025
Cash
893.55MCNYFY2025 · Dec 31, 2025
Cash Equivalents
12.13MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
905.68MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.00BCNYFY2025 · Dec 31, 2025
Inventory
624.39MCNYFY2025 · Dec 31, 2025
Accounts Payable
554.54MCNYFY2025 · Dec 31, 2025
Short-term Debt
641.77MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
22.11MCNYFY2025 · Dec 31, 2025
Long-term Debt
382.11MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
4.03MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
135.25MCNYFY2025 · Dec 31, 2025
Retained Earnings
645.26MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.08BCNY
309.74M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
42.48CNYUpdated Sep 22, 2026
52-Week High
127.32CNYUpdated Sep 22, 2026
52-Week Change
19.00%
vs all stocks
Updated Sep 22, 2026
Beta
0.6170x
vs all stocks
Updated Sep 22, 2026
50-Day MA
67.66CNYUpdated Sep 22, 2026
200-Day MA
69.40CNYUpdated Sep 22, 2026
Avg 10-Day Volume
1.19MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
1.48MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.7900CNYUpdated Sep 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.